Genetic risk for attention-deficit/hyperactivity disorder predicts cognitive decline and development of Alzheimer’s disease pathophysiology in cognitively unimpaired older adults.
Leffa DT, Ferrari-Souza JP, Bellaver B, Tissot C, Ferreira PCL, Brum WS, Caye A, Lord J, Proitsi P, Martins-Silva T, Tovo-Rodrigues L, Tudorascu DL, Villemagne VL, Cohen AD, Lopez OL, Klunk WE, Karikari TK, Rosa-Neto P, Zimmer ER, Molina BSG, Rohde LA, Pascoal TA; Alzheimer’s Disease Neuroimaging Initiative.
Mol Psychiatry. 2022 Dec 8. doi: 10.1038/s41380-022-01867-2. Online ahead of print.
Endocannabinoid System Biomarkers in Alzheimer’s Disease.
Ferreira PCL, Bellaver B, Povala G, Brum WS, Tissot C, Badji A, Sloan ME, Benedet AL, Rosa-Neto P, Ashton NJ, Pascoal TA, Leuzy A, Zimmer ER.
Cannabis Cannabinoid Res. 2022 Nov 17. doi: 10.1089/can.2022.0151. Online ahead of print.
The association of age-related and off-target retention with longitudinal quantification of [18F]MK6240 tau-PET in target regions.
Tissot C, Servaes S, Lussier FZ, Ferrari-Souza JP, Therriault J, Ferreira PCL, Bezgin G, Bellaver B, Teixeira Leffa D, Mathotaarachchi SS, Chamoun M, Stevenson J, Rahmouni N, Kang MS, Pallen V, Poltronetti NM, Wang YT, Fernandez-Arias J, Benedet AL, Zimmer ER, Soucy JP, Tudorascu DL, Cohen AD, Sharp M, Gauthier S, Massarweh G, Lopresti BJ, Klunk WE, Baker SL, Villemagne VL, Rosa-Neto P, Pascoal TA.
J Nucl Med. 2022 Nov 17:jnumed.122.264434. doi: 10.2967/jnumed.122.264434. Online ahead of print.
Subjective cognitive decline in Brazil: Prevalence and association with dementia modifiable risk factors in a population-based study.
Borelli WV, Zimmer ER, Bieger A, Coelho B, Pascoal TA, Chaves MLF, Amariglio R, Castilhos RM.
Alzheimers Dement (Amst). 2022 Nov 14;14(1):e12368. doi: 10.1002/dad2.12368. eCollection 2022.
Author Correction: [11C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer’s disease.
Pascoal TA, Chamoun M, Lax E, Wey HY, Shin M, Ng KP, Kang MS, Mathotaarachchi S, Benedet AL, Therriault J, Lussier FZ, Schroeder FA, DuBois JM, Hightower BG, Gilbert TM, Zürcher NR, Wang C, Hopewell R, Chakravarty M, Savard M, Thomas E, Mohaddes S, Farzin S, Salaciak A, Tullo S, Cuello AC, Soucy JP, Massarweh G, Hwang H, Kobayashi E, Hyman BT, Dickerson BC, Guiot MC, Szyf M, Gauthier S, Hooker JM, Rosa-Neto P.
Nat Commun. 2022 Oct 3;13(1):5833. doi: 10.1038/s41467-022-33668-0.
Staging of Alzheimer’s disease: past, present, and future perspectives.
Therriault J, Zimmer ER, Benedet AL, Pascoal TA, Gauthier S, Rosa-Neto P.
Trends Mol Med. 2022 Sep;28(9):726-741. doi: 10.1016/j.molmed.2022.05.008. Epub 2022 Jun 15.
Intrinsic connectivity of the human brain provides scaffold for tau aggregation in clinical variants of Alzheimer’s disease.
Therriault J, Pascoal TA, Savard M, Mathotaarachchi S, Benedet AL, Chamoun M, Tissot C, Lussier FZ, Rahmouni N, Stevenson J, Qureshi MNI, Kang MS, Thomas É, Vitali P, Soucy JP, Massarweh G, Saha-Chaudhuri P, Gauthier S, Rosa-Neto P.
Sci Transl Med. 2022 Aug 24;14(659):eabc8693. doi: 10.1126/scitranslmed.abc8693. Epub 2022 Aug 24.
Comment on “Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases”.
Zimmer ER, Pascoal TA, Rosa-Neto P, Nordberg A, Pellerin L.
Sci Transl Med. 2022 Aug 24;14(659):eabm8302. doi: 10.1126/scitranslmed.abm8302. Epub 2022 Aug 24.
Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease.
Ferrari-Souza JP, Ferreira PCL, Bellaver B, Tissot C, Wang YT, Leffa DT, Brum WS, Benedet AL, Ashton NJ, De Bastiani MA, Rocha A, Therriault J, Lussier FZ, Chamoun M, Servaes S, Bezgin G, Kang MS, Stevenson J, Rahmouni N, Pallen V, Poltronetti NM, Klunk WE, Tudorascu DL, Cohen AD, Villemagne VL, Gauthier S, Blennow K, Zetterberg H, Souza DO, Karikari TK, Zimmer ER, Rosa-Neto P, Pascoal TA.
Mol Psychiatry. 2022 Aug 10. doi: 10.1038/s41380-022-01716-2. Online ahead of print.